Intuitive Drug Testing and Monitoring Solutions for Pain Medication Therapy

In 2016, an estimated 48.5 million Americans reported use of illicit drugs or misuse of prescription drugs in the past 12 months.

Pain Management

In 2016, the Centers for Disease Control and Prevention found that roughly 50 million adults in the United States suffer from chronic pain and another 19.6 million adults suffer from high-impact chronic pain.** With the extensive number of Americans living with pain, pain medication therapy by prescription opioids has gained significant acceptance. Due to this acceptance, in 1986, the World Health Organization adopted the 3-step Pain ladder, shown in Figure 1. Today, it still remains the standard and represents a roadmap for pain treatment.*** As pain medication therapy by prescription opioids continues to increase in America, so does opioid related addiction and deaths. Therefore, it is critical that pain management specialists implement effective drug testing and monitoring programs to reduce the risk of prescription misuse and addiction. HORIBA Medical is focused on providing simplified drug testing solutions for pain management specialist, allowing them to accurately test and monitor their patient’s drug use during drug therapy. We provide a line of high quality and economical automated toxicology analyzers, along with a comprehensive line of open channel drugs of abuse reagents, which can be placed on any clinical chemistry analyzer. Furthermore, we provide convenient and reliable solutions for laboratories that are implementing or performing in-house LC/MS drug confirmation testing.

Million - The Number of individuals over 12 years of age in the U.S. who misuse prescription pain relievers*

Million - The Number of opioid prescriptions given to patients in 2017*


Million - The Number of individuals in the U.S. who filled at least one prescription for an opioid in 2017*

Figure 1: WHO’s 3-step pain ladder***


*Centers for Disease Control and Prevention. 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes — United States. Surveillance Special Report 2pdf icon. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Published August 31, 2018.

**Dahlhamer J, Lucas J, Zelaya, C, et al. Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016. MMWR Morb Mortal Wkly Rep 2018;67:1001–1006. DOI:

***Stjernsward J, Colleau SM, Ventafridda V. The World Health Organization Cancer Pain and Palliative Care Program. Past, present, and future. J Pain Symptom Manage.1996;12(2):65-72.

Let Us Help You!

Let Us Help You!

Please fill out the form and we will contact you shortly with more information about our G6PD Reagent. 

Thank you! You will here from us soon!

Want More Information?

Want More Information?

Fill out the form below to receive more information about our COVID-19 Antibody Tests.

Thank you! We will contact you shortly!